Geriatric pharm Flashcards
What are some tools for medication decisions in older adults
BEERS LIST
- list of medications likely to cause adverse effects in elderly
phsyiological changes of aging in body composition
- decrease total body water
- decrease lean body mass
- increase BODY FAT
phsyiological chagnes associated in cardiovascular
- decrease myocardial sensitivity to Beta-adrenergic stimualtion
- Decrease baroreceptor activity
- decrease cardiac output
- increase total peripheral resistance
physiological changes asocaited with aging in liver
- decrease hepatic size
- decrease hepatic blood flow
physiological changes assocaited with pulmonary function
- decrease
- respiratory muscle strength
- chest wall compliance
- total alveolar surface
- vital capacity
- maximal breathing capacity
physiooigical changes assocaited with aging in renal
- decrease
- glomerular filtration rate
- renal blood flow
- filtration fraction
- tubular secretory function
- renal mass
phsyiological changes associated with aging in skeletal system
loss of skeletal bone mass (OSTEOPENIA)
phsyiological changes in elderly that can affect pharmacokienetics
- absorption = LEAST affected by aging
- First-pass metabolism = reduced with aging
- Distribution = differences in body composition
- Metabolism/clearance
- reduced liver function and blood flow
- reduced kidney function
describe effect of first pass metabolism on plasma drug conc
- First pass metabolism is often reduced in elderly
- potentially a lower dose requirement in elderly with drugs that are inactivated by first pass metabolism
- Potentially a HIGHER dose required in elderly with PRODRUGS that require activation by first pass liver metabolism
Age related changes that affect volume of distribution
- Tissue binding properties
- drugs which are tightly bound to tissue have LARGE Vd
- ELDERLY = decrease lean body mass and increase adiposity
- drugs bound to muscle have DECREASE Vd with aging
- DECREASE LOADING DOSE REQUIRED
- drugs bound to muscle have DECREASE Vd with aging
- Lipid water coefficient
- lipid soluble drugs have HIGHER Vd than water soluble drugs
- ELDERLY = INCREASE body fat and DECREASE in body WATER
- INCREASE Vd for lipid soluble drugs and DECREASE Vd for water soluble drugs
- Loading dose DECREASE in WATER SOLUBLE
- INCREASE half life in FAT SOLUBLE
- INCREASE Vd for lipid soluble drugs and DECREASE Vd for water soluble drugs
age related effects on hepative drug clearane
- EFFECTS OF AGING ON LIVER
- decrease blood flow
- reduced activity of phase I enzymes (cytochrome p450)
- NO EFFECT ON PHASE II ENZYME
capacity limited hepatic clearance
- Capcity limited
- drug whose hepatic clearance rate-limiting step is liver enzyme function
- clearane capacity limited drug is NOT AFFECTED by how fast the drug can get to the liver cells (flow rate)
- NO Change in an elderly patient hepatic clearance of a capacity limited drug if it metabolized by phase II enzymes
- DECREASED CLEARANCE if metabolized by PHase I enzymes
FLOW RATE LIMITED
- drug whose rate-limiteing hepatic clearance step is FLOW RATE (how fast it can get to liver cells)
- HAVE REDUCED HAPTIC CLEARANCE IN ELDERLY PATIENTS
drugs effect of hepatic clearance on maintenance doses
- REduce in hepatic clearance of drug requries LESS FREQUENT and LOWER MAINTENANCE DOSE
- NO CHANGE in maintenance dose for CAPACITY LIMITED DRUGS that are metabolized by phase II enzymes
- DECREASE in maintenance dose in CAPACITY LIMITED DRUGS that are metabolized by PHASE I enzymes
- DECREASE in maintenance dose in FLOW RATE LIMITED DRUGS
describe renal clearance
-
Renal excretion is DECREASED IN ELDERLY INDIVIDUALS
- Glomerular filtration rate (reduced by 15-40%
- Tubular secretion (polypharm increases risk of drugs competing for active transporters
-
CREATINE CLEARANCE is an INDEX OF GLOMERULAR FILTRATION RATE (GFR)
- conc in blood INCREASES and conc in urine DECREASES as renal function DECREASES